{"title":"抗淀粉样蛋白-Β抗阿尔茨海默病单克隆抗体可能是白内障治疗的潜在突破","authors":"","doi":"10.33140/nabcc.04.01.02","DOIUrl":null,"url":null,"abstract":"The opacification of the lens, called cataracts, is responsible for degrading visual acuity as a consequence of scattering the light as it passes through the lens. The ocular lens plays a pivotal part in focusing the light onto the retina, and its clarity is essential for visual acuity. In 2020, the prevalence of cataracts had been 15.2 million cases among over 50 years globally. It has been estimated by the year 2050, approximately 50 million people in the united states will suffer from cataracts. According to statistics, cataracts will increase with passing years.","PeriodicalId":168335,"journal":{"name":"New Advances in Brain & Critical Care","volume":"10 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anti-Amyloid-Β Monoclonal Antibodies against Alzheimer's Disease may be a Potential Breakthrough for Cataract Treatment\",\"authors\":\"\",\"doi\":\"10.33140/nabcc.04.01.02\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The opacification of the lens, called cataracts, is responsible for degrading visual acuity as a consequence of scattering the light as it passes through the lens. The ocular lens plays a pivotal part in focusing the light onto the retina, and its clarity is essential for visual acuity. In 2020, the prevalence of cataracts had been 15.2 million cases among over 50 years globally. It has been estimated by the year 2050, approximately 50 million people in the united states will suffer from cataracts. According to statistics, cataracts will increase with passing years.\",\"PeriodicalId\":168335,\"journal\":{\"name\":\"New Advances in Brain & Critical Care\",\"volume\":\"10 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"New Advances in Brain & Critical Care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33140/nabcc.04.01.02\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"New Advances in Brain & Critical Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33140/nabcc.04.01.02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Anti-Amyloid-Β Monoclonal Antibodies against Alzheimer's Disease may be a Potential Breakthrough for Cataract Treatment
The opacification of the lens, called cataracts, is responsible for degrading visual acuity as a consequence of scattering the light as it passes through the lens. The ocular lens plays a pivotal part in focusing the light onto the retina, and its clarity is essential for visual acuity. In 2020, the prevalence of cataracts had been 15.2 million cases among over 50 years globally. It has been estimated by the year 2050, approximately 50 million people in the united states will suffer from cataracts. According to statistics, cataracts will increase with passing years.